Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Bjørn, Jon
- Beteiligte Personen und Organisationen
-
Donia, Marco V.
Andersen, Rikke
Hadrup, Sine R.
Svane, Inge Marie
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P241
- URN
-
urn:nbn:de:1111-2016072654548
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bjørn, Jon
- Donia, Marco V.
- Andersen, Rikke
- Hadrup, Sine R.
- Svane, Inge Marie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
S47. Tumour infiltrating lymphocytes - a predictive marker?
Ipilimumab in patients with melanoma and autoimmune disease
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
S47. Tumour infiltrating lymphocytes - a predictive marker?
Ipilimumab in patients with melanoma and autoimmune disease
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma
S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
Tumor-Infiltrating Lymphocytes in Wilms Tumor
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
S47. Tumour infiltrating lymphocytes - a predictive marker?
Ipilimumab in patients with melanoma and autoimmune disease
Relevance of tumor-infiltrating lymphocytes in breast cancer